Clinical trial
A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis
NCT00244647 · Sarepta Therapeutics, Inc., Industry · Terminated
Key facts
| NCT number | NCT00244647 |
|---|---|
| Title | A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis |
| Official title | A Phase 1b, Randomized, Single Blind Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis |
| Lead sponsor | Sarepta Therapeutics, Inc., Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease, Coronary Stent Restenosis |
| Intervention type | Drug |
| Interventions | RESTEN-MP |
| Enrollment | 40 |
| Start date | Aug 1, 2003 |
| First posted | Oct 27, 2005 |
| Last update posted | Apr 10, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: